Ipca Laboratories Ltd (BOM:524494)
₹ 1557.15 25.65 (1.67%) Market Cap: 395.06 Bil Enterprise Value: 400.99 Bil PE Ratio: 68.50 PB Ratio: 6.24 GF Score: 91/100

Q2 2020 IPCA Laboratories Ltd Earnings Call Transcript

Nov 08, 2019 / 05:30AM GMT
Release Date Price: ₹534.58 (+0.61%)
Operator

Good day, ladies and gentlemen, and welcome to the Q2 FY '20 Earnings Conference Call of Ipca Laboratories Limited hosted by IDFC Securities. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nitin Agarwal from IDFC Securities. Thank you, and over to you, Mr. Agarwal.

Nitin Agarwal
IDFC Securities Limited, Research Division - Analyst

Thanks, Margaret. Good morning, everyone, and a very warm welcome to Ipca Lab's Q2 FY '20 Earnings Call hosted by IDFC Securities. On the call today, we have representing Ipca management, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company Secretary.

I hand over the call to the Ipca management team to make some opening comments, and then we'll open the floor for questions.

Please go ahead, sir.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Good morning, everyone. For Q2, our domestic formulation business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot